Chau, I.; Fakih, M.; GarcÃa-Alfonso, P.; Linke, Z.; Ruiz Casado, A.; Marques, E.P.; Picard, P.; Celanovic, M.; Cartwright, T.
Safety and Effectiveness of Aflibercept + Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) for the Treatment of Patients with Metastatic Colorectal Cancer (mCRC) in Current Clinical Practice: OZONE Study. Cancers 2020, 12, 657.
https://doi.org/10.3390/cancers12030657
AMA Style
Chau I, Fakih M, GarcÃa-Alfonso P, Linke Z, Ruiz Casado A, Marques EP, Picard P, Celanovic M, Cartwright T.
Safety and Effectiveness of Aflibercept + Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) for the Treatment of Patients with Metastatic Colorectal Cancer (mCRC) in Current Clinical Practice: OZONE Study. Cancers. 2020; 12(3):657.
https://doi.org/10.3390/cancers12030657
Chicago/Turabian Style
Chau, Ian, Marwan Fakih, Pilar GarcÃa-Alfonso, ZdenÄ•k Linke, Ana Ruiz Casado, Eduardo Polo Marques, Pascaline Picard, Marina Celanovic, and Thomas Cartwright.
2020. "Safety and Effectiveness of Aflibercept + Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) for the Treatment of Patients with Metastatic Colorectal Cancer (mCRC) in Current Clinical Practice: OZONE Study" Cancers 12, no. 3: 657.
https://doi.org/10.3390/cancers12030657
APA Style
Chau, I., Fakih, M., GarcÃa-Alfonso, P., Linke, Z., Ruiz Casado, A., Marques, E. P., Picard, P., Celanovic, M., & Cartwright, T.
(2020). Safety and Effectiveness of Aflibercept + Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) for the Treatment of Patients with Metastatic Colorectal Cancer (mCRC) in Current Clinical Practice: OZONE Study. Cancers, 12(3), 657.
https://doi.org/10.3390/cancers12030657
